Search

Search Constraints

You searched for: Author/Creator Watmuff, Maura

Search Results

1. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Issue 3 (16th March 2023)